These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1641255)

  • 21. Zidovudine-induced lactic acidosis with acute pancreatitis and myopathy: Lethal and rare complications.
    Mahto SK; Gupta PK; Taneja RS; Singh A
    Indian J Pharmacol; 2018; 50(4):212-214. PubMed ID: 30505059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exacerbation of HIV-associated myopathy by zidovudine.
    Berger JR; Shebert R; Gregorios JB
    AIDS; 1991 Feb; 5(2):229-30. PubMed ID: 2031699
    [No Abstract]   [Full Text] [Related]  

  • 23. Early features of zidovudine-associated myopathy: histopathological findings and clinical correlations.
    Cupler EJ; Danon MJ; Jay C; Hench K; Ropka M; Dalakas MC
    Acta Neuropathol; 1995; 90(1):1-6. PubMed ID: 7572071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Muscle disease, HIV and zidovudine: the spectrum of muscle disease in HIV-infected individuals treated with zidovudine.
    Manji H; Harrison MJ; Round JM; Jones DA; Connolly S; Fowler CJ; Williams I; Weller IV
    J Neurol; 1993 Sep; 240(8):479-88. PubMed ID: 8263554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Zidovudine-associated myopathy.
    Paradis J; Calis KA
    Am J Hosp Pharm; 1994 Dec; 51(24):3026-8. PubMed ID: 7856620
    [No Abstract]   [Full Text] [Related]  

  • 26. Turns-amplitude analysis assessment of myopathies in HIV-infected patients.
    Lefaucheur JP; Verroust J; Gherardi RK
    J Neurol Sci; 1996 Mar; 136(1-2):148-53. PubMed ID: 8815162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognosis in AZT myopathy.
    Chalmers AC; Greco CM; Miller RG
    Neurology; 1991 Aug; 41(8):1181-4. PubMed ID: 1714057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV or zidovudine myopathy?
    Kieburtz K
    Neurology; 1994 Feb; 44(2):361; author reply 362-4. PubMed ID: 8309596
    [No Abstract]   [Full Text] [Related]  

  • 29. Cytochrome c oxidase reaction improves histopathological assessment of zidovudine myopathy.
    Chariot P; Monnet I; Gherardi R
    Ann Neurol; 1993 Oct; 34(4):561-5. PubMed ID: 8215243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of the blood lactate:pyruvate ratio as a noninvasive test for the diagnosis of zidovudine myopathy.
    Chariot P; Monnet I; Mouchet M; Rohr M; Lefaucheur JP; Dubreuil-Lemaire ML; Chousterman M; Gherardi R
    Arthritis Rheum; 1994 Apr; 37(4):583-6. PubMed ID: 8147937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zidovudine-induced mitochondrial disorder with massive liver steatosis, myopathy, lactic acidosis, and mitochondrial DNA depletion.
    Chariot P; Drogou I; de Lacroix-Szmania I; Eliezer-Vanerot MC; Chazaud B; Lombès A; Schaeffer A; Zafrani ES
    J Hepatol; 1999 Jan; 30(1):156-60. PubMed ID: 9927163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Peripheral nerve diseases and myopathies associated with HIV infection].
    Nervenarzt; 2000 Jun; 71(6):442-50. PubMed ID: 10919138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mitochondrial abnormalities in human immunodeficiency virus-associated myopathy.
    Morgello S; Wolfe D; Godfrey E; Feinstein R; Tagliati M; Simpson DM
    Acta Neuropathol; 1995; 90(4):366-74. PubMed ID: 8546027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytokine expression in the muscle of HIV-infected patients: evidence for interleukin-1 alpha accumulation in mitochondria of AZT fibers.
    Gherardi RK; Florea-Strat A; Fromont G; Poron F; Sabourin JC; Authier J
    Ann Neurol; 1994 Nov; 36(5):752-8. PubMed ID: 7979221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of myopathy in a placebo-controlled zidovudine trial.
    Simpson DM; Slasor P; Dafni U; Berger J; Fischl MA; Hall C
    Muscle Nerve; 1997 Mar; 20(3):382-5. PubMed ID: 9052824
    [No Abstract]   [Full Text] [Related]  

  • 36. 31P magnetic resonance spectroscopy suggests impaired mitochondrial function in AZT-treated HIV-infected patients.
    Weissman JD; Constantinitis I; Hudgins P; Wallace DC
    Neurology; 1992 Mar; 42(3 Pt 1):619-23. PubMed ID: 1549225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retroviruses and inflammatory myopathies in humans and primates.
    Dalakas MC
    Baillieres Clin Neurol; 1993 Nov; 2(3):659-91. PubMed ID: 8156147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitochondrial myopathy caused by long-term zidovudine therapy.
    Gold R; Meurers B; Reichmann H
    N Engl J Med; 1990 Oct; 323(14):994. PubMed ID: 2402267
    [No Abstract]   [Full Text] [Related]  

  • 39. Type B lactic acidosis in an AIDS patient treated with zidovudine.
    Aggarwal A; al-Talib K; Alabrash M
    Md Med J; 1996 Nov; 45(11):929-31. PubMed ID: 8942169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absence of cardiac toxicity of zidovudine in infants. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection Study Group.
    Lipshultz SE; Easley KA; Orav EJ; Kaplan S; Starc TJ; Bricker JT; Lai WW; Moodie DS; Sopko G; McIntosh K; Colan SD
    N Engl J Med; 2000 Sep; 343(11):759-66. PubMed ID: 10984563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.